Profile picture

Professor Elaine Hylek

Boston University, Boston (United States of America)
Follow
Biography
Elaine M. Hylek, MD, MPH, is a Professor of Medicine at Boston University School of Medicine. She received her MD from the University of Pittsburgh School Of Medicine and a Masters in Public Health (quantitative methods) from Harvard University. She completed her residency training in internal medicine at Massachusetts General Hospital and Harvard Medical School in Boston, Massachusetts. Her research areas include arterial (stroke) and venous thrombosis, anticoagulant therapies, and atrial fibrillation. She has served as PI on several NIH grants, Executive Steering Committees for international trials and registries, Event Adjudication Committees, Guideline Committees, and Data Safety Monitoring Boards. She has also served as the Late Breaking Clinical Trial Discussant for multiple trials in the field of thrombosis. Dr. Hylek is a former Section Editor for Thrombosis and Haemostasis, and a founding member of the International Society of Thrombosis and Haemostasis World Thrombosis Day.
Logo ESC

Contributor content

Practical dilemmas in atrial fibrillation therapies
Session
Practical dilemmas in atrial fibrillation therapies
2 September 2024
Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations
Session
Atrial fibrillation management and outcomes in high-risk atrial fibrillation populations
2 September 2024
Ask the Trialists from Hot Line 6
Session
Ask the Trialists from Hot Line 6
1 September 2024
Management of atrial fibrillation: knowns and unknowns
Session
Management of atrial fibrillation: knowns and unknowns
31 August 2024
Atrial fibrillation and comorbidities: practical guidance for optimising stroke prevention
Session
Atrial fibrillation and comorbidities: practical guidance for optimising stroke prevention
27 August 2022
Atrial fibrillation patients in focus: clinical cases and guidelines
Session
Atrial fibrillation patients in focus: clinical cases and guidelines
29 August 2020
Antithrombotic therapy for coronary artery disease: opportunities and challenges
Session
Antithrombotic therapy for coronary artery disease: opportunities and challenges
2 September 2019
10 years since RE-LY: applying innovations in anticoagulation
Session
10 years since RE-LY: applying innovations in anticoagulation
1 September 2019
Identifying and managing complications of atrial fibrillation
Session
Identifying and managing complications of atrial fibrillation
1 September 2019
Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice
Session
Anticoagulation and your atrial fibrillation patients: bringing it all together in clinical practice
27 August 2018

ESC 365 is supported by